Published in Pharma Investments, Ventures and Law Weekly, May 16th, 2004
The company also announced that Elizabeth A. Czerepak, a managing partner of BSHI, has joined Affymax's board of directors. Czerepak brings 18 years of experience in the pharmaceutical industry to Affymax. Existing investors, Apax Partners, MPM Capital and Sprout Group, also participated in the extension as well as an earlier close of this financing round. The company raised a total of $40 million from the Series C financing.
"As we prepare to enter the clinic with our first drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.